BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 10285379)

  • 1. Potential liability for institutional review boards and bioethics committees.
    Reider A
    Home Care Econ; 1987; 1(4):119-21. PubMed ID: 10285379
    [No Abstract]   [Full Text] [Related]  

  • 2. Institutional review boards and bioethics committees: their role in ensuring ethical home care research.
    Cary AH
    Home Care Econ; 1987; 1(4):113-8. PubMed ID: 10285378
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule.
    Fed Regist; 1991 Jun; 56(117):28025-9. PubMed ID: 10112215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Proposed rule.
    Fed Regist; 1988 Nov; 53(218):45678-82. PubMed ID: 10290533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of human subjects: Institutional Review Board; report and recommendations of National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
    Fed Regist; 1978 Nov; 43(231):56173-98. PubMed ID: 10239683
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical lasers and the law.
    Norton ML; Norton EV
    Leg Med; 1986; ():134-47. PubMed ID: 3312887
    [No Abstract]   [Full Text] [Related]  

  • 7. Institutional review boards (IRBs) and reproductive medicine: guidelines for compliance.
    Cackowski A
    J Health Hosp Law; 1996; 29(2):121-4. PubMed ID: 10160175
    [No Abstract]   [Full Text] [Related]  

  • 8. More tales from institutional review boards.
    Neuhauser D
    Health Matrix Clevel; 1994; 4(1):153-8. PubMed ID: 10142174
    [No Abstract]   [Full Text] [Related]  

  • 9. Protecting "human guinea pigs".
    Thompson RC
    FDA Consum; 1986 Dec-1987 Jan; 20(10):12-5. PubMed ID: 10311766
    [No Abstract]   [Full Text] [Related]  

  • 10. Researcher liability for negligence in human subject research: informed consent and researcher malpractice actions.
    Jansson RL
    Wash Law Rev; 2003 Feb; 78(1):229-63. PubMed ID: 15732212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When research turns into liability.
    Rozovsky LE; Rozovsky FA
    Health Care (Don Mills); 1989; 31(9):38. PubMed ID: 10296538
    [No Abstract]   [Full Text] [Related]  

  • 12. Position statement of the AFCR on the issue of regulation of institutional review boards by the FDA.
    Clin Res; 1979 Apr; 27(2):109-11. PubMed ID: 10241073
    [No Abstract]   [Full Text] [Related]  

  • 13. Malpractice by committee.
    Can Doct; 1987 May; 53(5):GP22. PubMed ID: 10282055
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the risk of legal liability for ethics committees.
    Merritt AL
    Hastings Cent Rep; 1988; 18(1):13-4. PubMed ID: 3350642
    [No Abstract]   [Full Text] [Related]  

  • 15. Institutional review boards, research on children, and informed consent of parents: walking the tightrope between encouraging vital experimentation and protecting subjects' rights.
    Katerberg RJ
    J Coll Univ Law; 1998; 24(3):545-79. PubMed ID: 16331880
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with boards and commissions concerned with research ethics in the United States.
    McCarthy CR
    Prog Clin Biol Res; 1983; 128():111-22. PubMed ID: 6634724
    [No Abstract]   [Full Text] [Related]  

  • 17. Standards for institutional review boards for clinical investigations: proposed establishment of regulations.
    Fed Regist; 1978 Aug; 43(153):5185-208. PubMed ID: 10237259
    [No Abstract]   [Full Text] [Related]  

  • 18. Why new human research guidelines raise legal worries.
    Rozovsky LE; Rozovsky FA
    Health Care (Don Mills); 1988 Oct; 30(7):62. PubMed ID: 10290076
    [No Abstract]   [Full Text] [Related]  

  • 19. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical battery and failure to obtain informed consent: Illinois court decision suggests potential for IRB liability.
    LeBlang TR
    IRB; 1995; 17(3):10-1. PubMed ID: 11654268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.